Cancer News and Research

Latest Cancer News and Research

Low-dose aspirin use associated with reduced ovarian cancer risk

Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer. A new study co-led by Moffitt Cancer Center found that women who reported taking a low-dose aspirin every day had a 23 percent lower risk of ovarian cancer compared to nonaspirin users.

4 Oct 2018

New report provides overview of cancer risk among U.S. Hispanics/Latinos

The cancer burden in Puerto Rico, a U.S. territory with a 99% Hispanic population, is substantially different from that of Hispanics in the continental U.S., according to Cancer Statistics for Hispanics/Latinos, 2018.

4 Oct 2018

Podcast: KHN’s ‘What the Health?’ Some things old, some things new

Congress passed major health-related legislation in time for the fiscal year, which began Monday, including a broad bill to address the opioid epidemic and a spending bill for the Department of Health and Human Services.

4 Oct 2018

Sunscreen chemicals in seawater could pose risk to human health, finds study

A study by Hong Kong Baptist University has detected an extensive amount of sunscreen chemicals in seawater that could pose a risk to human health.

4 Oct 2018

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

The University of Texas MD Anderson Cancer Center and Cyclacel Pharmaceuticals, Inc., today announced a three-year strategic alliance agreement that will enable clinical evaluation for safety and efficacy of three Cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and other advanced leukemias.

4 Oct 2018

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced it will present new data from the Phase 2 Challenge Study of its H1 influenza oral tablet vaccine at IDWeek 2018 in San Francisco on Saturday, October 6, 2018.

4 Oct 2018

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.

4 Oct 2018

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

A robot could become the 'weapon' of choice for detecting and treating the most common cancer in men, improving results and reducing side effects.

4 Oct 2018

Working with Next Health World Innovation Forum to build a healthier future

The Innovation Forum is partnering with the Milner Therapeutics Institute in 2019 for the Next Health World Innovation Forum – a new international healthcare conference taking place from 26-27 June 2019, in Cambridge, UK.

4 Oct 2018

Australia will soon become the first country to eradicate cervical cancer

According to an announcement from the International Papillomavirus Society, Australia could soon become the first country to eradicate cervical cancer.

4 Oct 2018

Processed meat consumption may increase breast cancer risk, meta-analysis suggests

Studies on red and processed meat consumption with breast cancer risk have generated inconsistent results. An International Journal of Cancer analysis has now examined all published studies on the topic.

4 Oct 2018

Medrobotics markets its Flex Robotic System for gastroenterology applications in Europe

Medrobotics Corp. today announced the first sale in Europe of their Flex Robotic System for gastroenterology applications.

4 Oct 2018

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

Over half of all breast cancers carry genetic defects in the p53 gene, a powerful tumor suppressor. Loss of this gene increases the risk of getting breast cancer and the resultant cancers become highly resistant to treatment.

4 Oct 2018

New approach helps identify molecular alterations linked to prognosis, resistance of cancer

A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer was developed by the research group led by Nuno Barbosa Morais, Group Leader at Instituto de Medicina Molecular João Lobo Antunes, and now published open access in Nucleic Acids Research.

4 Oct 2018

Two-pronged approach represents potential strategy for targeting latent reservoir of HIV

With more than 35 million people worldwide living with the virus and nearly 2 million new cases each year, the human immunodeficiency virus remains a major global epidemic.

4 Oct 2018

Stevens researchers develop new class of molecules for breast cancer treatment

Researchers at Stevens Institute of Technology and colleagues have designed and developed a new class of molecules that use a never-before-known mechanism that may halt or destroy breast cancer tumors, particularly for patients with drug-resistant or dangerously metastatic stages of the disease.

4 Oct 2018

Women with epilepsy have five times greater risk of dying during pregnancy

The risk of dying during pregnancy is negligible for the average Danish woman, but if the woman in question has epilepsy, the probability must be multiplied by five. This is the central result presented in a comprehensive epidemiological study that researchers from Health, Aarhus University, are behind.

3 Oct 2018

Cancer News and Research

Latest Cancer News and Research

Low-dose aspirin use associated with reduced ovarian cancer risk

New report provides overview of cancer risk among U.S. Hispanics/Latinos

Podcast: KHN’s ‘What the Health?’ Some things old, some things new

Sunscreen chemicals in seawater could pose risk to human health, finds study

MD Anderson and Cyclacel announce strategic alliance to evaluate novel drugs for hematological malignancies

Vaxart to present new data from Phase 2 Challenge Study of H1 influenza oral tablet vaccine

HalioDx announces availability of Brightplex, a high capacity IHC multiplex technology

Robot could become the 'weapon' of choice for detecting and treating prostate cancer

Working with Next Health World Innovation Forum to build a healthier future

Australia will soon become the first country to eradicate cervical cancer

Processed meat consumption may increase breast cancer risk, meta-analysis suggests

Medrobotics markets its Flex Robotic System for gastroenterology applications in Europe

Blocking stress-responsive protein reduces loss of tumor suppressor gene in breast cancer

New approach helps identify molecular alterations linked to prognosis, resistance of cancer

Two-pronged approach represents potential strategy for targeting latent reservoir of HIV

Stevens researchers develop new class of molecules for breast cancer treatment

Women with epilepsy have five times greater risk of dying during pregnancy

Special glowing paper strip as rapid, reliable test for infectious diseases

Even lightest daily drinkers have increased mortality risk

DNA Script successfully synthesizes world's first 150-nucleotide strand of DNA

Cancer Research - Second Edition eBook

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Newsletters you may be interested in